Objective: Although the use of 18F-fluorodeoxyglucose (FDG) PET for evaluating lymphoma
is gaining in popularity, PET is not yet universally available and large prospective …

Recently, we suggested the potential use of 67Gascintigraphy to evaluate the rapidity of
response to treatment, if there is the possibility to achieve better overall response by …

Gallium-67 scintigraphy (GS) has the ability to provide important diagnostic and prognostic
information for the evaluation of patients with lymphoma. GS is superior to morphologic …

Abstract Until recently, gallium-67 scintigraphy (GS) has been the best available functional
imaging modality for evaluating patients with non-Hodgkin's lymphoma (NHL) and Hodgkin's …

Advances in molecular biology and immunology are converging with the development of
better diagnostic techniques and chemotherapeutic agents, resulting in improved …

The clinical impact of gallium-67 scintigraphy before and after therapy for lymphoma
remains controversial. The aims of this study were:(1) to compare the staging of lymphoma …

PURPOSE: To compare gallium 67 (67Ga) scintigraphy and camera-based
fluorodeoxyglucose (FDG) positron emission tomography (PET) in the evaluation of patients …

Positron emission tomography (PET) imaging using [F-18] fluorodeoxyglucose (FDG) has
become a useful imaging modality in the staging and treatment evaluation algorithm for …

The usefulness and complementarity of gallium (67 Ga) scintigraphy and computed
tomography (CT) in the management of patients with lymphoma have been extensively …

Positron emission tomography (PET) imaging has become a very useful technique for
staging and monitoring therapy response in lymphoma, providing unique information about …